| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |